Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$209.01 - $232.56 $29,261 - $32,558
140 Added 0.86%
16,473 $3.6 Million
Q4 2023

Feb 07, 2024

BUY
$197.69 - $227.29 $474,851 - $545,950
2,402 Added 17.24%
16,333 $3.71 Million
Q4 2023

Feb 05, 2024

SELL
$197.69 - $227.29 $416,928 - $479,354
-2,109 Reduced 13.15%
13,931 $3.17 Million
Q3 2023

Nov 13, 2023

BUY
$201.05 - $221.7 $104,143 - $114,840
518 Added 3.34%
16,040 $3.22 Million
Q2 2023

Aug 10, 2023

SELL
$211.93 - $241.33 $16,106 - $18,341
-76 Reduced 0.49%
15,522 $3.75 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $168,353 - $215,520
822 Added 5.56%
15,598 $3.2 Million
Q2 2022

Aug 15, 2022

BUY
$213.86 - $277.87 $187,127 - $243,136
875 Added 6.29%
14,776 $3.46 Million
Q1 2022

May 16, 2022

SELL
$259.82 - $298.18 $7,794 - $8,945
-30 Reduced 0.22%
13,901 $3.67 Million
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $8,148 - $9,426
30 Added 0.22%
13,931 $4.38 Million
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $120,645 - $135,361
-439 Reduced 3.06%
13,901 $3.91 Million
Q2 2021

Aug 16, 2021

BUY
$251.87 - $278.14 $1.4 Million - $1.54 Million
5,552 Added 63.18%
14,340 $3.96 Million
Q1 2021

May 17, 2021

SELL
$204.88 - $255.03 $166,362 - $207,084
-812 Reduced 8.46%
8,788 $2.24 Million
Q4 2020

Feb 12, 2021

SELL
$186.91 - $214.42 $226,721 - $260,091
-1,213 Reduced 11.22%
9,600 $1.95 Million
Q3 2020

Nov 12, 2020

BUY
$167.03 - $201.3 $1.81 Million - $2.18 Million
10,813 New
10,813 $2.04 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.